NCI-H69/LX10

96042331, human lung, Not specified

• 分類程式碼代碼: 41106514

属性

• product name: NCI-H69/LX10, 96042331
• 生物源: human lung
• 增長模式: Aggregates in suspension
• 染色體組型: Not specified
• 形態學: Not specified
• 產品: Not specified
• 受體: Not specified
• 技術: cell culture | mammalian: suitable
• 相關疾病: cancer
• 運輸包裝: dry ice
• 儲存溫度: −196°C

说明

細胞系來源

Human small cell lung cancer, drug-resistant

細胞系描述

The drug-resistant cell line NCI-H69/LX10 has been derived from the parent line NCI-H69 (ECACC No 91091802). It is recommended to culture the cells without drug upon resuscitation; add doxorubicine once growth is fully established.

應用

Drug-resistance studies

培養基

RPMI 1640 + 2mM Glutamine + 1.0 μg/ml doxorubicine + 10% Foetal Bovine Serum (FBS).

例行更新培養

Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO₂, 37ºC; resuscitate in drug-free medium and add drug after growth has been established.

其他說明

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.